Hope for Advanced HNSCC at Last From ImmunotherapyHope for Advanced HNSCC at Last From Immunotherapy

Nivolumab significantly improved survival for patients with advanced refractory head and neck cancer. Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news